ThinkGenetic announces that Chief Genetic Officer, Dawn Laney, MS, CGC, CCRC, will be participating in a 19th Annual WORLDSymposium™ Satellite Symposia entitled “Understanding Phenotypic Variability in Lysosomal Diseases – Gaining a Foothold in Precision Medicine” sponsored by Takeda Pharmaceutical Company Limited.
[Audio Interview] ThinkGenetic Leadership Team Interview with RV Radio Part 1
The ThinkGenetic leadership team was recently interviewed for the RV Radio podcast with Cian Robinson, discussing the origin of ThinkGenetic while giving insight into what it’s like to be diagnosed with a genetic condition later in life when doctors are stumped and existing tools to diagnose are limited.
[VIDEO] New Study Results: Severity scoring system to identify patient risk for genetic conditions
Development and implementation of an automated severity scoring system to identify patients at possible increased risk for specific genetic conditions NSGC 2021 Poster UM353
[Press Release] ThinkGenetic Announces Integration of Innovative Diagnostic Aid in Takeda Pilot Awareness Initiative
ThinkGenetic, Inc. is set to launch three disease-specific versions of the diagnostic aid, SymptomMatcher™ for upcoming pilot awareness initiatives by global biopharmaceutical leader, Takeda Pharmaceutical Company Limited.
